Education
About Us
Working with TipRanks
Follow Us
FNK - ETF AI Analysis
Top Page
First Trust Mid Cap Value AlphaDEX Fund (FNK)
Rating:69Neutral
Price Target:
$60.00
Positive Factors
Broad Sector Diversification
The ETF is spread across 11 sectors, reducing the risk of being overly reliant on any single industry.
Strong U.S. Focus
With nearly all assets invested in U.S. companies, the fund benefits from exposure to one of the world's largest and most stable economies.
Steady Asset Base
The fund has a healthy level of assets under management, indicating investor confidence and stability.
Negative Factors
Underperforming Top Holdings
Several of the largest positions, such as Avantor and Molina Healthcare, have shown weak year-to-date performance, which could drag on returns.
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.
Minimal Global Exposure
The fund is heavily concentrated in U.S. companies, offering little diversification across international markets.
FNK vs. SPDR S&P 500 ETF (SPY)
AUM188.90M
RegionNorth America
Expense Ratio0.70%
Beta0.93
IssuerFirst Trust
Inception DateApr 19, 2011
Dividend Yield1.6%
Asset ClassEquity
Index TrackedNASDAQ AlphaDEX Mid Cap Value Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,750
30 Day Avg. Volume7,917
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
63.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering226
FNK Summary
The First Trust Mid Cap Value AlphaDEX Fund (FNK) is an ETF that focuses on mid-sized companies in the U.S., using a smart strategy to pick stocks with strong value traits like low price-to-book ratios and solid cash flow. It follows the NASDAQ AlphaDEX Mid Cap Value Index and includes well-known companies like Molson Coors and Gap Inc. Investors might consider FNK for portfolio diversification and to tap into the growth potential of mid-cap stocks that are often overlooked. However, since it focuses on mid-cap companies, its performance can be more volatile compared to larger, more established firms.
How much will it cost me?The expense ratio for the First Trust Mid Cap Value AlphaDEX Fund (FNK) is 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because FNK uses an actively managed smart beta strategy to select stocks with strong value characteristics, rather than passively tracking an index.
What would affect this ETF?FNK's focus on U.S. mid-cap value stocks could benefit from economic recovery and increased consumer spending, especially in sectors like financials and consumer cyclicals, which are heavily weighted in the fund. However, rising interest rates or economic slowdowns could negatively impact mid-cap companies and sectors like real estate and energy, which are more sensitive to such changes. Regulatory shifts or geopolitical tensions affecting U.S.-based businesses may also influence the ETF's performance.
FNK Top 10 Holdings
The First Trust Mid Cap Value AlphaDEX Fund (FNK) is leaning heavily into financials and consumer cyclical sectors, which together make up a significant portion of its portfolio. Universal Health Services is a bright spot, showing steady growth and efficient debt management, while Portland GE is also contributing positively with strong industrial growth and cost control. On the flip side, Molina Healthcare and Conagra Brands are dragging performance due to cost pressures and revenue challenges. With its focus on U.S. mid-cap value stocks, FNK offers a concentrated play on overlooked companies with potential for long-term growth.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Fluor | 0.88% | $1.68M | $7.88B | -7.79% | 73 Outperform | |
| Knight Transportation | 0.87% | $1.65M | $7.32B | -14.76% | 64 Neutral | |
| Alcoa | 0.85% | $1.62M | $9.53B | -9.32% | 77 Outperform | |
| NOV | 0.84% | $1.59M | $5.33B | -3.76% | 72 Outperform | |
| Gap Inc | 0.81% | $1.55M | $8.48B | 10.17% | 69 Neutral | |
| Universal Health | 0.81% | $1.54M | $13.81B | 5.72% | 78 Outperform | |
| CNX Resources | 0.80% | $1.52M | $4.54B | -0.82% | 60 Neutral | |
| LKQ | 0.80% | $1.51M | $8.18B | -13.39% | 70 Neutral | |
| Lear | 0.79% | $1.51M | $5.57B | 8.20% | 73 Outperform | |
| Portland GE | 0.79% | $1.50M | $5.00B | -0.91% | 73 Outperform |
FNK Technical Analysis
Negative
―
Price Trends
55.12
Negative
53.87
Negative
52.10
Positive
Market Momentum
-0.33
Positive
39.96
Neutral
7.82
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FNK, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 54.36, equal to the 50-day MA of 55.12, and equal to the 200-day MA of 52.10, indicating a neutral trend. The MACD of -0.33 indicates Positive momentum. The RSI at 39.96 is Neutral, neither overbought nor oversold. The STOCH value of 7.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FNK.
FNK Peer Comparison
Comparison Results
Performance Comparison
FNK
First Trust Mid Cap Value AlphaDEX Fund
53.40
1.06
2.03%
IMCV
iShares Morningstar Mid-Cap ETF
―
―
―
NUMV
Nuveen ESG Mid-Cap Value ETF
―
―
―
XMVM
Invesco S&P MidCap Value with Momentum ETF
―
―
―
RFV
Invesco S&P Midcap 400 Pure Value ETF
―
―
―
AVMV
Avantis U.S. Mid Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents